HeimBiotek Forms Consortium for Virus Diagnostic Kit Development
HeimBiotek announced its success in developing a BK virus diagnostic kit in February and is now forming consortia in South Korea and the United States to accelerate the development of various virus diagnostic kits.
The company will leverage its proprietary Specific Bidirectional Elongation Polymerase Chain Reaction (SBDE™ PCR) technology to develop miRNA analysis diagnostic kits. Consortia in both countries will spearhead this research and development.
HeimBiotek, known for its advanced molecular diagnostic technologies, first commercialized miRNA research kits in South Korea using its proprietary SBDE™-PCR technology. In May, the company completed the world's first BK virus diagnostic kit through joint research with Kyunghee University Medical Center using miRNA analysis.
HeimBiotek entered the miRNA detection and analysis market as the third company globally and the first in South Korea. Their Reverse Transcription Quantitative PCR (RT-qPCR) technology offers higher reactivity and accuracy compared to existing miRNA detection methods.
In South Korea, HeimBiotek is collaborating with Yonsei University Severance Hospital to develop diagnostic kits capable of simultaneously detecting BKV, EBV, and CMV.
In the United States, the company is working with UNT Children's Medical Center to develop molecular diagnostic kits for RSV and secondary infections.
This content is partially excerpted from a news article.